{"transactions":[{"id":2346126,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":129409,"kind":"organization","name":"A.G.P. / ALLIANCE GLOBAL PARTNERS CORP.","position":1,"cik":"0000318492","reported_name":"A.G.P. / ALLIANCE GLOBAL PARTNERS CORP.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2022-03-08T13:51:21.000Z","date":"2022-03-08","kind":"other","acquired":false,"shares":3427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer of shares to certain investors for no consideration as contemplated in connection with Issuer's initial public offering because underwriters' over-allotment option was not fully exercised."}],"balance_after":446843,"source":{"system":"sec-edgar","filing":"0001209191-22-016941","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318492/000120919122016941/doc4.xml","form_type":"4"}},{"id":2410867,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":129409,"kind":"organization","name":"A.G.P. / ALLIANCE GLOBAL PARTNERS CORP.","position":1,"cik":"0000318492","reported_name":"A.G.P. / ALLIANCE GLOBAL PARTNERS CORP.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2022-02-07T19:36:29.000Z","date":"2022-02-03","kind":"other","acquired":false,"shares":49730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cancellation of 49,730 shares (\"Shares\") of Issuer's Class B common stock as contemplated in connection with Issuer's initial public offering. Such Shares were forfeited and cancelled for no consideration because underwriters' over-allotment option was not fully exercised."}],"balance_after":450270,"source":{"system":"sec-edgar","filing":"0001209191-22-007614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318492/000120919122007614/doc4.xml","form_type":"4"}},{"id":2545913,"issuer":{"id":134710,"kind":"organization","name":"Mount Rainier Acquisition Corp.","symbol":"RNER"},"owners":[{"id":129409,"kind":"organization","name":"A.G.P. / ALLIANCE GLOBAL PARTNERS CORP.","position":1,"cik":"0000318492","reported_name":"A.G.P. / ALLIANCE GLOBAL PARTNERS CORP.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-08T13:44:20.000Z","date":"2021-10-07","kind":"other","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer of shares pursuant to the Underwriting Agreement, and related agreements, including that certain letter agreement (as amended and restated, the \"Side Letter\"), by and among the Company, DC Rainier SPV LLC (\"Sponsor\"), and Reporting Person, as representative of the underwriters (\"Representative\") in the Company's initial public offering (\"IPO\"). As provided in the Side Letter, upon full exercise of the over-allotment option by underwriters in the IPO, Representative agreed to assign and transfer 50,000 shares of common stock to the Company's Sponsor. Such option was exercised in full concurrently with consummation of the Company's IPO on October 7, 2021."}],"balance_after":865000,"source":{"system":"sec-edgar","filing":"0001209191-21-060015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318492/000120919121060015/doc4.xml","form_type":"4"}}]}